Wärmländer Sebastian K T S, Lakela Amanda L, Berntsson Elina, Jarvet Jüri, Gräslund Astrid
Chemistry Section, Arrhenius Laboratories, Stockholm University, 114 19 Stockholm, Sweden.
CellPept Sweden AB, Kvarngatan 10B, 118 47 Stockholm, Sweden.
ACS Omega. 2025 Apr 22;10(17):17133-17142. doi: 10.1021/acsomega.4c05312. eCollection 2025 May 6.
Human calcitonin is a 32-residue peptide hormone that binds to the calcitonin receptor (CTR) and is involved in calcium regulation. The amino acid sequence displays a hydrophilic central segment flanked by hydrophobic C- and N-terminal regions with a net charge of zero at neutral pH. This makes the molecule amphiphilic and conformationally flexible, and different CTR variants preferentially recognize different structural conformations of calcitonin. The peptide is secreted from the thyroid gland and is overproduced in some forms of thyroid cancer and can then form cell-toxic aggregates. Characterizing the structural properties of calcitonin under different conditions is, therefore, important for understanding its receptor-binding and self-aggregation properties. Here, we used circular dichroism (CD) spectroscopy to monitor the secondary structure of human calcitonin in different environments. Calcitonin monomers were found to display a random coil structure with a significant amount of PPII-helix components in phosphate buffer, pH 7.3, at physiological temperatures. When agitated, the peptide formed soluble aggregates over time with mainly an antiparallel β-sheet secondary structure. In the presence of micelles of differently charged surfactants, monomeric calcitonin formed a pure α-helix structure with cationic CTAB, a combination of α-helix and β-sheet with anionic SDS and with zwitterionic SB3-14, and remained mainly random coil with noncharged DDM. Thus, the charge of the surfactant headgroup was found to be an important parameter for calcitonin's interactions with membrane-mimicking micelles. Similar but not identical interactions with the surfactants were observed under the oxidizing and reducing conditions.
人降钙素是一种由32个氨基酸残基组成的肽类激素,它与降钙素受体(CTR)结合并参与钙调节。其氨基酸序列显示出一个亲水性的中央片段,两侧是疏水性的C端和N端区域,在中性pH下净电荷为零。这使得该分子具有两亲性且构象灵活,不同的CTR变体优先识别降钙素的不同结构构象。该肽由甲状腺分泌,在某些形式的甲状腺癌中会过度产生,然后可形成细胞毒性聚集体。因此,表征不同条件下降钙素的结构特性对于理解其受体结合和自聚集特性很重要。在这里,我们使用圆二色性(CD)光谱来监测人降钙素在不同环境中的二级结构。发现在生理温度下,pH 7.3的磷酸盐缓冲液中,降钙素单体呈现出具有大量PPII螺旋成分的无规卷曲结构。搅拌时,该肽会随着时间的推移形成可溶性聚集体,其二级结构主要为反平行β折叠。在带有不同电荷的表面活性剂胶束存在的情况下,单体降钙素与阳离子CTAB形成纯α螺旋结构,与阴离子SDS形成α螺旋和β折叠的组合,与两性离子SB3 - 14也有类似组合,而与不带电荷的DDM则主要保持无规卷曲结构。因此,发现表面活性剂头基的电荷是降钙素与模拟膜胶束相互作用的一个重要参数。在氧化和还原条件下观察到与表面活性剂有相似但不完全相同的相互作用。